Showing results (31-40 of 86) with videos related to

Sort By:
Pageof 9
Oncotarget|October 17, 2018
TRPV2 is a novel biomarker and therapeutic target in triple negative breast cancerMohamad Elbaz, Dinesh Ahirwar, Zhang Xiaoli, et al.
Human Pathology|May 21, 2009
Deposition of calcium salts in a case of pulmonary zygomycosis: histopathologic and chemical findingsNegar Rassaei, Konstantin Shilo, Michael R Lewin-Smith, et al.
Cell Death & Disease|November 1, 2025
S100A9 enhances tumor immune suppression and cancer cell survival in small cell lung cancerManish Charan, Sanjay Mishra, Konstantin Shilo, et al.
Journal of Oncology|May 24, 2012
Altered p16(INK4) and RB1 Expressions Are Associated with Poor Prognosis in Patients with Nonsmall Cell Lung CancerWeiqiang Zhao, Cheng C Huang, Gregory A Otterson, et al.
Archives of Pathology & Laboratory Medicine|June 7, 2007
Occult primary parotid gland acinic cell adenocarcinoma presenting with extensive lung metastasisFabio Tavora, Negar Rassaei, Konstantin Shilo, et al.
Breast Cancer Research and Treatment|March 29, 2013
Differential role of psoriasin (S100A7) in estrogen receptor α positive and negative breast cancer cells occur through actin remodelingAmita Sneh, Yadwinder S Deol, Akaansha Ganju, et al.
JAMA Otolaryngology-- Head & Neck Surgery|February 22, 2014
Thymoma and parathyroid adenoma: false-positive imaging and intriguing laboratory test resultsLauren C Cunningham, Jun-Ge Yu, Konstantin Shilo, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 23, 2020
Circulating MicroRNAs and Extracellular Vesicle-Containing MicroRNAs as Response Biomarkers of Anti-programmed Cell Death Protein 1 or Programmed Death-Ligand 1 Therapy in NSCLCTakehito Shukuya, Vikas Ghai, Joseph M Amann, et al.
Cancer Prevention Research (Philadelphia, Pa.)|November 25, 2010
Cannabinoid receptors, CB1 and CB2, as novel targets for inhibition of non-small cell lung cancer growth and metastasisAnju Preet, Zahida Qamri, Mohd W Nasser, et al.
Molecular Cancer Therapeutics|October 29, 2017
Histone Deacetylase Inhibition Enhances the Antitumor Activity of a MEK Inhibitor in Lung Cancer Cells Harboring RAS MutationsTadaaki Yamada, Joseph M Amann, Azusa Tanimoto, et al.
Pageof 9